These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results. Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755 [TBL] [Abstract][Full Text] [Related]
25. Clarithromycin and azithromycin: new macrolide antibiotics. Piscitelli SC; Danziger LH; Rodvold KA Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921 [TBL] [Abstract][Full Text] [Related]
27. The newer macrolides. Azithromycin and clarithromycin. Zuckerman JM; Kaye KM Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441 [TBL] [Abstract][Full Text] [Related]
28. Choosing the right macrolide antibiotic. A guide to selection. Charles L; Segreti J Drugs; 1997 Mar; 53(3):349-57. PubMed ID: 9074839 [TBL] [Abstract][Full Text] [Related]
29. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia. Zhanel GG; Hartel E; Adam H; Zelenitsky S; Zhanel MA; Golden A; Schweizer F; Gorityala B; Lagacé-Wiens PR; Walkty AJ; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA Drugs; 2016 Dec; 76(18):1737-1757. PubMed ID: 27909995 [TBL] [Abstract][Full Text] [Related]
30. Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin. McConnell SA; Amsden GW Pharmacotherapy; 1999 Apr; 19(4):404-15. PubMed ID: 10212011 [TBL] [Abstract][Full Text] [Related]
31. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients. Langtry HD; Brogden RN Drugs; 1997 Jun; 53(6):973-1004. PubMed ID: 9179528 [TBL] [Abstract][Full Text] [Related]
32. Preliminary Study on Drug Susceptibility Profile and Resistance Mechanisms to Macrolides of Clinical Isolates of Non-tuberculous Mycobacteria from China. Li F; Li GL; Pang H; Liu HC; Xiao TY; Li SJ; Luo Q; Jiang Y; Wang RB; Wan KL Biomed Environ Sci; 2018 Apr; 31(4):290-299. PubMed ID: 29773092 [TBL] [Abstract][Full Text] [Related]
33. Macrolide drug interactions: an update. Pai MP; Graci DM; Amsden GW Ann Pharmacother; 2000 Apr; 34(4):495-513. PubMed ID: 10772438 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic drug interactions of macrolides. Periti P; Mazzei T; Mini E; Novelli A Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528 [TBL] [Abstract][Full Text] [Related]
35. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Peters DH; Clissold SP Drugs; 1992 Jul; 44(1):117-64. PubMed ID: 1379907 [TBL] [Abstract][Full Text] [Related]